Vildaglip M Tablet

Composition of Vildaglip M Tablet

Vildaglip M Tablet contains Vildagliptin (50mg). It belongs to the DPP-4 inhibitor + Biguanide class of medicines.

Uses of Vildaglip M Tablet

Treatment of type 2 diabetes mellitus to improve glycaemic control along with diet and exercise.

Key benefits

• Lowers fasting and post-meal blood glucose
• Improves HbA1c control
• Low risk of hypoglycaemia when used without insulin/sulfonylureas
• Helps improve insulin sensitivity
• Convenient combination therapy for type 2 diabetes

How Vildaglip M Tablet works

Vildagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing insulin release and reducing glucagon secretion in a glucose-dependent manner. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering blood glucose levels.

How to take Vildaglip M Tablet

Take by mouth as prescribed by a doctor, usually with meals to reduce stomach upset. Swallow tablet whole with water; do not crush/chew unless advised. Regularly monitor blood glucose and follow diet/exercise advice.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Vildaglip M Tablet

Most side effects of Vildaglip M are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• vomiting
• diarrhoea
• abdominal pain
• loss of appetite
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• low blood sugar (especially with other antidiabetics)
• metallic taste

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Vildaglip M Tablet

Warnings and precautions

Type 1 diabetes and diabetic ketoacidosis: not indicated. Metformin can rarely cause lactic acidosis—risk increases with kidney impairment, dehydration, severe infection, hypoxia/heart failure, excessive alcohol use; assess renal function before and during therapy. Vildagliptin may affect liver enzymes—periodic liver function tests recommended; stop if jaundice or significant LFT rise. Use caution in elderly and in renal/hepatic impairment; dose adjustments may be required. Temporarily stop metformin around iodinated contrast procedures and major surgery as advised by doctor. Watch for symptoms of pancreatitis (severe abdominal pain) and severe allergic reactions; seek medical help.

Do not take Vildaglip M if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis.

Interactions with other medicines

Alcohol (increases lactic acidosis risk), iodinated contrast media, carbonic anhydrase inhibitors (e.g., topiramate, acetazolamide), cimetidine (may increase metformin levels), diuretics and ACE inhibitors/ARBs (may affect kidney function), corticosteroids and sympathomimetics (may raise glucose), insulin/sulfonylureas (increased hypoglycaemia risk).

How to store Vildaglip M Tablet

Store below 25°C in a cool, dry place away from moisture and direct light. Keep out of reach of children.

Expert advice for Vildaglip M Tablet

It can be taken with or without food, at the same time each day. Keep up your diet and activity — this medicine supports them.

Manufacturer and class

Manufacturer:

BIOCEUTICS

Therapeutic class:

Antidiabetic

Drug class:

DPP-4 inhibitor + Biguanide